Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPAST | Q9UBP0 | 2/20 | 0.74 |
| ▸ | IGF1R | P08069 | 5/20 | 0.43 |
| ▸ | ROCK2 | O75116 | 4/20 | 0.40 |
| ▸ | ROCK1 | Q13464 | 3/20 | 0.39 |
| ▸ | PAK4 | O96013 | 6/20 | 0.39 |
| ▸ | PAK1 | Q13153 | 3/20 | 0.39 |
| ▸ | PLK4 | O00444 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22034761 | 1.00 | SPAST (0.74) | SPASTIGF1RROCK2ROCK1PAK4 | |
| SCHEMBL22035049 | 0.85 | SPAST (1.00) | SPASTIGF1RPAK4PAK1 | |
| SCHEMBL22035048 | 0.85 | SPAST (1.00) | SPASTIGF1RPAK4PAK1 | |
| SCHEMBL22072741 | 0.83 | SPAST (0.76) | SPASTIGF1RROCK2ROCK1PAK4 | |
| SCHEMBL22072528 | 0.82 | SPAST (0.75) | SPASTIGF1RROCK2ROCK1PAK4 | |
| SCHEMBL22072737 | 0.82 | SPAST (0.75) | SPASTIGF1RROCK2ROCK1PAK4 | |
| SCHEMBL22072740 | 0.81 | SPAST (0.76) | SPASTIGF1RROCK2ROCK1PAK4 | |
| SCHEMBL22072742 | 0.81 | SPAST (0.72) | SPASTIGF1RROCK2ROCK1PAK4 | |
| SCHEMBL2044426 | 0.78 | SPAST (0.51) | SPASTROCK2ROCK1PAK4 | |
| SCHEMBL22035098 | 0.76 | SPAST (1.00) | SPASTIGF1RROCK2ROCK1PAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020118183-A1 | 2,4-DIAMINOPYRIMIDINE BICYCLES FOR TREATING CANCER | KAPOOR TARUN M (US) | 2020-06-11 | — | — | WO | disclosed |